1. « santepubliquefrance.fr ».
2. Updated guidelines (2021) for management and follow-up of asthmatic patients of the French Society of Pneumology (SPLF) and the French Society of Pediatric Pneumology and Allergology (SP2A);Raherison-Semjen;Respir Med Res,2022
3. « Global Initiative for Asthma. 2021 GINA Main Report, global strategy for asthma management and prevention (2021 update) ».
4. Safety and tolerability of omalizumab (Xolair), a recombinant humanized monoclonal anti-IgE antibody;Deniz;Clin Rev Allergy Immunol,2005
5. Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma;Berger;Ann Allergy Asthma Immunol,2003